Assessment of the rs6498486 Polymorphism in the ERCC4 (XPF) Gene and Its Possible Association with Breast Cancer Risk in Bangladeshi Women - Top-Institutions - MDSpire

Assessment of the rs6498486 Polymorphism in the ERCC4 (XPF) Gene and Its Possible Association with Breast Cancer Risk in Bangladeshi Women

By
Iffat Hossain
Sanjida Chowdhury Ivy
Mohammad Safiqul Islam
Mohammad Shahriar
February 17, 2026
0 min

Bmc Cancer

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

#1

National Cancer Institute (NCI)

Bethesda, MD
Key Differentiators
- Oncology
- Cancer Genetics
- Molecular Epidemiology
#2

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Oncology
- Cancer Genetics
- Translational Research
#3

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Oncology
- Cancer Genomics
- Molecular Biology
#4

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Oncology
- Cancer Genetics
- Precision Medicine
#5

The University of Texas Southwestern Medical Center

Dallas, TX
Key Differentiators
- Molecular Genetics
- Oncology
- Cancer Biology

Original Source(s)

Bmc Cancer

Assessment of the rs6498486 Polymorphism in the ERCC4 (XPF) Gene and Its Possible Association with Breast Cancer Risk in Bangladeshi Women

by Iffat Hossain, Sanjida Chowdhury Ivy, Mohammad Safiqul Islam, Mohammad Shahriar
February 17, 2026

Related Content

Jama Network Open

GLP-1 Receptor Agonists and Cancer—The Promise Is Real

by Richard C. Wender
May 11, 2026

Frontiers In Endocrinology

Future landscapes of women’s hormone-sensitive cancers: unraveling global trends, age stratification, and regional inequities (1990–2035)

American Journal Of Epidemiology

Historical redlining, breast cancer survival, and the mediating and modifying role of contemporary neighborhood socioeconomic conditions